Back to Search

GLAXO

NSEHealthcareCap: ₹42254.95 Cr

Glaxosmithkline Pharmaceuticals Ltd.

+4.15%YTD

Non-Compliant (Not Permissible)

Evaluated using MSCI criteria

Reasons for Non-Compliance:
  • Liquidity: Cash 63.75% exceeds limit 33.33%.

Market Fundamentals

Live NSE/BSE
Market Cap
₹42254.95 Cr
P/E Ratio
39.6x
P/B Ratio
18.6x
52W High
₹3,120.7
52W Low
₹2,088.1
Div. Yield
229.00%
Shares O/S
16.94 Cr

Where Does the Money Come From?

Revenue breakdown for Glaxosmithkline Pharmaceuticals Ltd.

Core Healthcare OperationsPermissible Operating Activity

Permissible: Core operations in Healthcare.

98.5%of Total Revenue
Treasury Interest & Secondary Non-Operating IncomeImpure Interest Income (Riba)

Non-operating interest income earned from cash and fixed deposits. Requires purification.

1.5%of Total Revenue
About Glaxosmithkline Pharmaceuticals Ltd.

Permissible: Core operations in Healthcare.

Interest-Bearing Debt Ratio
0.77%Max: ≤ 33.0%
Cash & Securities Liquidity
63.75%Max: ≤ 33.0%
Impure Revenue Ratio
1.49%Max: ≤ 5.0%
Screening Denominator
Total Assets

Purification & Zakat Calculator

Calculate how much to donate for GLAXO

⚠️ Note: GLAXO is not Halal. The right step is to sell this stock, not just purify the dividends. Keeping a non-compliant investment is not resolved by Sadaqah.